Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-11-001413

Director acquired 2,784 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SAXE JON S Director 2011-12-14 Option exercise +2,784 $1.25 $3,480 20,138 D
Derivatives
SAXE JON S Director 2011-12-14 Option exercise · Warrant −2,784 0 D
Loading xslF345X03/form4-12162011_051210.xml…